|
|
|
|
| LEADER |
00000cam a2200000Mi 4500 |
| 001 |
ocn923262981 |
| 003 |
OCoLC |
| 005 |
20240623213015.0 |
| 006 |
m o d |
| 007 |
cr |n||||||||| |
| 008 |
151010s1900 dcu o 000 0 eng d |
| 040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d OCLCQ
|d MERUC
|d OCLCQ
|d ZCU
|d ICG
|d OCLCO
|d OCLCF
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|d DKC
|d AU@
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCL
|
| 020 |
|
|
|a 9780309586504
|
| 020 |
|
|
|a 030958650X
|
| 035 |
|
|
|a (OCoLC)923262981
|
| 043 |
|
|
|a n-us---
|
| 050 |
|
4 |
|a R853.H8W66
|
| 049 |
|
|
|a HCDD
|
| 100 |
1 |
|
|a T, Committee on the Ethical and Legal Issues Relating.
|
| 245 |
1 |
0 |
|a Ethical and Legal Issues of Including Women in Clinical Studies :
|b Workshop and Commissioned Papers.
|
| 260 |
|
|
|a Washington :
|b National Academies Press,
|c 1900.
|
| 300 |
|
|
|a 1 online resource (264 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a ""WOMEN AND HEALTH RESEARCH""; ""Copyright""; ""Preface""; ""Contents""; ""Women's Participation in Clinical Research: From Protectionism to Access""; ""CURRENT FEDERAL POLICY""; ""PROTECTIONIST POLICIES""; ""ADVENT OF INCLUSIONARY POLICIES""; ""CONCLUSION""; ""NOTES""; ""Women in Clinical Studies: A Feminist View""; ""NOTES""; ""Ethical Issues Related to the Inclusion of Pregnant Women in Clinical Trials (I)""; ""THE PREGNANT WOMAN AS SUBJECT""; ""Therapeutic: To Meet the Health Needs of the Mother""; ""Nontherapeutic Research: Not Meeting the Health Needs of the Pregnant Woman""
|
| 505 |
8 |
|
|a ""THE FETUS AS SUBJECT""""Therapeutic: To Meet the Health Needs of the Fetus""; ""Nontherapeutic Fetal Research: Not to Meet the Fetus's Health Needs""; ""NOTES""; ""Ethical Issues Related to the Inclusion of Pregnant Women in Clinical Trials (II)""; ""REFERENCES""; ""Ethical Issues Related to the Inclusion of Women of Childbearing Age in Clinical Trials""; ""NOTES""; ""Health Consequences of Exclusion or Underrepresentation of Women in Clinical Studies (I)""; ""TYPES OF INFORMATION DEFICITS""; ""TYPES OF CONSEQUENCES""; ""Morbidity and Mortality""; ""Diagnosis and Treatment Patterns""
|
| 505 |
8 |
|
|a ""Treatment Outcomes""""Provider Perceptions""; ""CONCLUSIONS""; ""NOTES""; ""Health Consequences of Exclusion or Underrepresentation of Women in Clinical Studies (II)""; ""Recruitment and Retention of Women in Clinical Studies: Theoretical Perspectives and Methodological Considerations""; ""THE DYNAMICS OF RECRUITMENT AND RETENTION""; ""CROSS-CULTURAL DIFFERENCES: MEN VS. WOMEN""; ""GENDER DIFFERENCES: IMPLICATIONS FOR RESEARCH""; ""METHODOLOGICAL CONSIDERATIONS FOR RESEARCHERS""; ""REFERENCES""; ""Recruitment and Retention of Women of Color in Clinical Studies""; ""NOTES""
|
| 505 |
8 |
|
|a ""Recruitment and Retention of Women in Clinical Studies: Ethical Considerations""""INCENTIVES TO ENROLL AND TO CONTINUE PARTICIPATION""; ""FREE ABORTION AS AN INCENTIVE""; ""DEALING WITH DROPOUTS""; ""COSTS OF INVOLVING WOMEN AS RESEARCH SUBJECTS""; ""TWO SEPARATE AGENDAS ON THE INCLUSION OF WOMEN""; ""WOMEN IN (SOME) DEVELOPING COUNTRIES""; ""REFERENCES""; ""Impact of Current Federal Regulations on the Inclusion of Female Subjects in Clinical Studies""; ""THE IMPACT OF PRESENT LAW""; ""Regulations that Appear to Limit Women's Participation in Clinical Research""
|
| 505 |
8 |
|
|a ""FDA Definition of ""Childbearing Potential"" and Required Prior Reproductive Studies""""DHHS Limitations on Research with Pregnant Women""; ""Federal Requirements that Support the Inclusion of Women in Clinical Research""; ""FDA Premarketing Testing""; ""DHHS Regulations on Research with Children""; ""RECOMMENDED CHANGES IN THE FEDERAL LAW""; ""Amendment of FDA Regulations""; ""Amendment of DHHS Regulations""; ""National Institutes of Health Policy""; ""CONCLUSION""; ""NOTES""; ""Brief Overview of Constitutional Issues Raised by the Exclusion of Women from Research Trials""
|
| 500 |
|
|
|a ""Disparate treatment, disparate benefits, and equal opportunity""
|
| 610 |
1 |
0 |
|a United States.
|t National Institutes of Health Revitalization Act of 1993.
|
| 630 |
0 |
7 |
|a National Institutes of Health Revitalization Act of 1993 (United States)
|2 fast
|
| 650 |
|
0 |
|a Human experimentation in medicine
|x Law and legislation.
|
| 650 |
|
0 |
|a Human experimentation in medicine
|x Moral and ethical aspects.
|
| 650 |
|
0 |
|a Women
|x Health and hygiene
|x Research
|x Moral and ethical aspects.
|
| 650 |
|
7 |
|a Human experimentation in medicine
|x Law and legislation
|2 fast
|
| 650 |
|
7 |
|a Human experimentation in medicine
|x Moral and ethical aspects
|2 fast
|
| 700 |
1 |
|
|a Mastroianni, Anna C.
|
| 700 |
1 |
|
|a Faden, Ruth R.
|
| 758 |
|
|
|i has work:
|a Ethical and Legal Issues of Including Women in Clinical Studies (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCXWFvMvPGWFXqXcV44brYK
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
| 776 |
0 |
8 |
|i Print version:
|a T, Committee on the Ethical and Legal Issues Relating.
|t Ethical and Legal Issues of Including Women in Clinical Studies : Workshop and Commissioned Papers.
|d Washington : National Academies Press, ©1900
|z 9780309050401
|
| 856 |
4 |
0 |
|u https://ebookcentral.proquest.com/lib/holycrosscollege-ebooks/detail.action?docID=3376332
|y Click for online access
|
| 903 |
|
|
|a EBC-AC
|
| 994 |
|
|
|a 92
|b HCD
|